BridgeBio Pharma, Inc. (BBIO) Discusses Positive FORTIFY Phase III Interim Results in Limb-Girdle Muscular Dystrophy Type 2I/R9 - Slideshow (NASDAQ:BBIO) 2025-10-27

Group 1 - The article does not provide any specific content related to a company or industry [1]